Video Experimental Relacionado
Updated: Oct 8, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 26, 2009
La anisodamina inhibe la síntesis de tromboxano, la agregación de granulocitos y la agregación de plaquetas. Un
JAMA
|March 12, 1982
Resumen
El clorhidrato de anisodamina, un medicamento vasoactivo chino, inhibe moderadamente la agregación de granulocitos y inhibe fuertemente la agregación de plaquetas. Esto sugiere que su efecto terapéutico en el choque bacteriémico puede implicar el bloqueo de la síntesis de tromboxano.
Área de la Ciencia:
- Farmacología Farmacología.
- La bioquímica es la bioquímica.
- Medicina de cuidados críticos Medicina de cuidados críticos.
Sus antecedentes:
- El clorhidrato de anisodamina es un fármaco vasoactivo utilizado en China.
- Se reconoce su eficacia en el choque bacteriémico, pero su mecanismo de acción no está claro.
- La agregación de plaquetas y granulocitos está implicada en la fisiopatología del choque.
Objetivo del estudio:
- Para investigar el mecanismo potencial de acción del clorhidrato de anisodamina.
- Para determinar si el clorhidrato de anisodamina inhibe la agregación de plaquetas y/o granulocitos.
- Para explorar el efecto del clorhidrato de anisodamina en la síntesis de tromboxano.
Principales métodos:
- Prueba del efecto del clorhidrato de anisodamina en la agregación plaquetaria humana in vitro.
- Prueba del efecto del clorhidrato de anisodamina en la agregación de granulocitos humanos in vitro.
- Medición de la síntesis de tromboxano en plaquetas tratadas con clorhidrato de anisodamina.
Principales resultados:
- El clorhidrato de anisodamina demostró una modesta inhibición de la agregación de los granulocitos.
- El clorhidrato de anisodamina mostró una poderosa inhibición de la agregación plaquetaria.
- La síntesis de tromboxano se inhibió significativamente en las plaquetas tratadas con clorhidrato de anisodamina.
Conclusiones:
- La potente inhibición de la agregación plaquetaria por el clorhidrato de anisodamina es un hallazgo clave.
- La inhibición de la síntesis de tromboxano sugiere un mecanismo bioquímico que involucra a la ciclooxigenasa o la tromboxano sintetasa.
- Estos hallazgos proporcionan información sobre la acción terapéutica del clorhidrato de anisodamina en el choque bacteriémico.
Videos de Conceptos Relacionados
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...